CIIT Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

Standing Committee on International Trade (CIIT)

43rd Parliament, 2nd Session

Meeting 14

Monday, February 1, 2021, 11:04 a.m. to 1:15 p.m.

Room 425, Wellington Building, 197 Sparks Street

Webcast

Presiding

Hon. Judy A. Sgro (Liberal)

Expand All Collapse All

Members of the Committee present

Liberal

Conservative

Bloc Québécois

Simon-Pierre Savard-Tremblay

NDP

Daniel Blaikie

In attendance

Library of Parliament

• Anne-Marie Therrien-Tremblay, Analyst

• Bashar Abu Taleb, Analyst

• Offah Obale, Analyst

Meeting Requested by Four Members of the Committee to Discuss their Request to Undertake a Study of the Impact on Canada of the European Union Transparency and Authorisation Mechanism for Exports of COVID-19 Vaccines

Pursuant to Standing Order 106(4), the committee commenced consideration of the request by four members of the committee to undertake a study of the Impact on Canada of the European Union Transparency and Authorisation Mechanism for Exports of COVID-19 Vaccines.

Motion

Tracy Gray moved, — That, given the announced Transparency and Authorisation Mechanism for Exports of COVID-19 Vaccines by the European Union, the committee invite the minister of Small Business, Export Promotion and International Trade and her officials to appear before the committee for no less than two hours regarding matters related to the European Union’s export controls and its potential impacts on Canada’s COVID-19 vaccination strategy, and that this meeting occur no later than February 10, 2021.

After debate, the question was put on the motion and it was agreed to.

At 11:11 a.m., the sitting was suspended.

At 11:25 a.m., the sitting resumed.

The Impact on Canada of the European Union Transparency and Authorisation Mechanism for Exports of COVID-19 Vaccines

Appearing

• Hon. Mary Ng, P.C., M.P., Minister of International Trade

Witnesses

Department of Foreign Affairs, Trade and Development

• John Hannaford, Deputy Minister, International Trade

• Sandra McCardell, Assistant Deputy Minister, Europe, Arctic, Middle East and Maghreb

• Steve Verheul, Chief Negotiator and Assistant Deputy Minister, Trade Policy and Negotiations

• Sara Wilshaw, Chief Trade Commissioner, Assistant Deputy Minister, International Business Development, Investment and Innovation

Pursuant to Standing Order 108(2) and the motion adopted by the committee on Monday, February 1, 2021, the committee commenced its study of the impact on Canada of the European Union transparency and authorisation mechanism for exports of COVID-19 vaccines.

The Minister made a statement and, with John Hannaford and Steve Verheul, answered questions.

At 1:15 p.m., the committee adjourned to the call of the Chair.

Christine Lafrance

Clerk of the Committee